The annual BIO-Europe Spring® conference is the premier springtime partnering conference for the biotechnology industry. For its 2017 edition, BIO-Europe Spring comes to Barcelona, Spain on March 20–22, 2017. Meet Dr. Paul Helbling from Dualsystems Biotech AG to learn more about the new LRC-TriCEPSTM (Ligand-receptor capture) technology to identify targets and off-targets of your ligands…
The Annual Meeting of the LS2 Section Proteomics, Thun, 20 April – 21 April 2017
Thun, Thursday 20 April – Friday 21 April 2017
The LS2 SPS meeting is an annual event gathering more than 100 proteomic/life science researchers from Switzerland and neighboring countries. The meeting will be held on April 20 and 21, 2017 in Seminarhotel Freienhof in Thun, Switzerland. With Profs. Neil Kelleher and Ruedi Aebersold we have an excellent line-up of keynote speakers!
Dr. Neil Kelleher, Northwestern University, Chicago, USA
“Tri-level proteomics to track protein-level dynamics in cancer biology”
Dr. Ruedi Aebersold, ETH Zurich, Switzerland
“The proteome in context”
The presentation of Prof. Dr. Wollscheid at the Bio-Technopark was a successful start of the new seminar series.
Last week Dualsystems invited Prof. Wollscheid to give a presentation in a new seminar series at the Bio-Technopark in Schlieren. Nearly 80 people listened intensely to Prof. Bernd Wollscheid’s talk about “Decoding Ligand-Receptor Interactions”. Prof. Wollscheid presented his work that is trying to bridge the gap between the genotype and the phenotype and especially focusing on the protein-protein interactions at the surfaceome. After his impressive talk and during the party that followed Prof. Wollscheid had lively discussions with many participants and tried to answer all upcoming questions.
Prof. Dr. Bernd Wollscheid is a Principal Investigator and Head of the Biomedical Proteomics Platform at the Department of Health Sciences and Technology of Swiss Federal Institute of Technology in Zurich, Switzerland.
Bio-Europe November 7-9, 2016 Colonge, Germany
November 7–9, 2016
KoelnMesse – Congress Center North,
The 22nd annual BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry. Delegates from all parts of the biotechnology value chain come to BIO-Europe to quickly identify, engage and enter into strategic relationships that drive their businesses successfully forward. Investment and collaboration opportunities developed in prior BIO-Europe conferences have produced many highly successful business partnerships. This year´s BIO-Europe partnering event will again draw over 3,000 industry attendees from nearly 60 countries, representing more than 1,800 companies for three days of high level networking.
Partnering at BIO-Europe 2016 is powered by EBD Group’s partneringONE®, the industry’s most advanced networking system, which enables participants to efficiently mine a large pool of potential partners, and identify and pre-arrange private one-to-one meetings with literally dozens of company targets.
Meet Dr. Paul Helbling from Dualsystems Biotech AG to learn more about the new LRC-TriCEPSTM (Ligand-receptor capture) technology to identify targets and off-targets of your ligands on the living cells. Send a meeting invitation via the conference partnering system.
You also can reach him via email email@example.com or mobile +41 76 422 55 05
Now, we are looking for a
Proteomics Specialist (Scientist 60%-100%)
to cover for a maternity leave.
Your responsibilities include
- Proteomics data analyses (LTQ Orbitrap, Progenesis etc.)
- Perform customer projects and internal method development projects in the wet lab for LRC-TriCEPs
- Cell culture
- Sample preparation for LC-MS/MS
- Develop with the team the expansion of the current Services
Interested? More details and information on this site
Presentation by Prof. Bernd Wollscheid about “Decoding Ligand-Receptor Interactions” at the Bio-Technopark
“Decoding Ligand-Receptor Interactions”
at the Bio-Technopark in Schlieren-Zürich October 4th 2016.
Dualsystems would like to invite you to participate at Bernd’s presentation and the social event afterwards.
The Wollscheid research group at the Institute of Molecular Systems Biology at ETH Zurich is focusing on biomedical research bridging the gap in understanding the genotype to phenotype transition via detailed analysis of the proteotype. Dr. Wollscheid will present a short summary of his recent surfaceome research with a focus on a new chemoproteomic technology for the unbiased detection of ligand-receptor interactions on living cells.
We are looking forward to welcome you at this exiting talk. In case you are not able to participate please contact us.
Here a Link to the Bio-Technopark post
The LRC-TriCEPS applied to human primary T-cells
Zellwerk GmbH, Germany and Dualsystems Biotech AG, Zurich joined forces and conducted successfully an entire LRC- TriCEPSTM experiment on primary T-cells.
Positive control ligand (included in the kit): Anti-CD28 antibody the protein CD28
Ligand of interest: Anti-TCR2 α/β antibody
Cells used: human primary T-cells
Read all detail from the experiment about Example of LRC-TriCEPS T-cells
BioPharm America September 13–15, 2016 Boston Marriott Copley Place, Boston, MA
BioPharm America™ is where biotech industry partnerships get started. Meet face-to-face with Dr. Paul Helbling from Dualsystems Biotech AG to learn more about the new LRC-TriCEPSTM (Ligand-receptor capture) technology to identify targets and off-targets of your ligands on the living cells.
Please send a meeting invitation via the conference partnering system to Dr. Paul Helbling.
Alternatively, you can reach him via email firstname.lastname@example.org or mobile +41 76 422 55 05
TriCEPSTM V.3.0 enables receptor identification for your orphan ligands at the surface of living cells without genetic manipulation.
Key features of the new TriCEPSTM V.3.0 and LRC- TriCEPSTM technology are: Read more
LRC TriCEPS Service
Dualsystems Biotech AG
Dr. Paul Helbling
phone +41 44 738 50 00
fax +41 44 738 50 05